antineoplastics
404 results
201 - 300
lomustine- mechlorethamine
- melphalan
- nilutamide
- tamoxifen
- toremifene
- vinBLAStine
- cetuximab
- erlotinib
- panitumumab
- dasatinib
- lapatinib
- interferon beta-1a
- nilotinib
- vemurafenib
- regorafenib
- vincristine liposome
- asparaginase Erwinia chrysanthemi
- obinutuzumab
- belinostat
- peginterferon beta-1a
- cobimetinib
- daratumumab
- elotuzumab
- abemaciclib
- neratinib
- enasidenib
- encorafenib
- alpelisib
- binimetinib
- dacomitinib
- polatuzumab vedotin
- isatuximab
- larotrectinib
- enfortumab vedotin
- gilteritinib
- DOXOrubicin hydrochloride
- capivasertib
- denileukin diftitox
- elacestrant
- elranatamab
- fruquintinib
- inavolisib
- margetuximab
- tafasitamab
- talquetamab
- tebentafusp
- eflornithine (systemic)
- aminoglutethimide
- cycloPHOSphamide
- epiRUBicin
- fluorouracil
- hydroxyurea
- irinotecan
- pegfilgrastim
- temozolomide
- PEMEtrexed
- rasburicase
- diethylstilbestrol
- lenalidomide
- pertuzumab
- mechlorethamine (topical)
- afatinib
- blinatumomab
- nivolumab
- ado-trastuzumab
- alectinib
- necitumumab
- ramucirumab
- avelumab
- cemiplimab
- moxetumumab pasudotox
- ivosidenib
- brentuximab vedotin
- tretinoin (systemic)
- dostarlimab
- ruxolitinib (systemic)
- olutasidenib
- ripretinib
- arsenic trioxide
- dacarbazine
- DOCEtaxel
- goserelin
- IDArubicin
- mercaptopurine
- mitoMYcin
- thioguanine
- methyl aminolevulinate
- DOXOrubicin, liposomal
- everolimus
- pembrolizumab
- osimertinib
- trifluridine/tipiracil
- olaratumab
- erdafitinib
- pemigatinib
- decitabine/cedazuridine
- tisotumab vedotin
- belzutifan
- futibatinib